|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2002-4-22
|
|
pubmed:abstractText |
Cyclosporine (CsA) is effective for the treatment of children with steroid-dependent and -resistant nephrotic syndrome (NS), but it can result in chronic CsA nephrotoxicity including CsA-induced tubulointerstitial lesions. The factors responsible for the development of CsA-induced tubulointerstitial lesions are unknown.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0085-2538
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
61
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1801-5
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11967030-Biopsy,
pubmed-meshheading:11967030-Child,
pubmed-meshheading:11967030-Cyclosporine,
pubmed-meshheading:11967030-Female,
pubmed-meshheading:11967030-Humans,
pubmed-meshheading:11967030-Immunosuppressive Agents,
pubmed-meshheading:11967030-Logistic Models,
pubmed-meshheading:11967030-Male,
pubmed-meshheading:11967030-Nephritis, Interstitial,
pubmed-meshheading:11967030-Nephrosis, Lipoid,
pubmed-meshheading:11967030-Proteinuria,
pubmed-meshheading:11967030-Risk Factors
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome.
|
|
pubmed:affiliation |
Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan. kidney@kobe-u.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
